AU2022348938A1 - Imidazopyridazine il-17 inhibitor compounds - Google Patents

Imidazopyridazine il-17 inhibitor compounds Download PDF

Info

Publication number
AU2022348938A1
AU2022348938A1 AU2022348938A AU2022348938A AU2022348938A1 AU 2022348938 A1 AU2022348938 A1 AU 2022348938A1 AU 2022348938 A AU2022348938 A AU 2022348938A AU 2022348938 A AU2022348938 A AU 2022348938A AU 2022348938 A1 AU2022348938 A1 AU 2022348938A1
Authority
AU
Australia
Prior art keywords
alkyl
cycloalkyl
substituted
compound
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022348938A
Other languages
English (en)
Inventor
Douglas C. Behenna
Steven D. Goldberg
Deane GORDON
Luke E. HANNA
Steven A. LOSKOT
Stefan MCCARVER
Steven P. Meduna
Brock T. Shireman
Alexander E. VALDES
Jennifer D. Venable
Dongpei Wu
Xiaohua XUE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2022348938A1 publication Critical patent/AU2022348938A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2022348938A 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds Pending AU2022348938A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163248563P 2021-09-27 2021-09-27
US63/248,563 2021-09-27
US202163273407P 2021-10-29 2021-10-29
US63/273,407 2021-10-29
US202263371910P 2022-08-19 2022-08-19
US63/371,910 2022-08-19
PCT/US2022/077000 WO2023049886A1 (en) 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds

Publications (1)

Publication Number Publication Date
AU2022348938A1 true AU2022348938A1 (en) 2024-05-16

Family

ID=83693127

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022348938A Pending AU2022348938A1 (en) 2021-09-27 2022-09-26 Imidazopyridazine il-17 inhibitor compounds

Country Status (10)

Country Link
US (2) US12215111B2 (https=)
EP (1) EP4408529A1 (https=)
JP (1) JP2024536863A (https=)
KR (1) KR20240082371A (https=)
AU (1) AU2022348938A1 (https=)
CA (1) CA3233625A1 (https=)
MX (1) MX2024003770A (https=)
TW (1) TW202329933A (https=)
UY (1) UY39957A (https=)
WO (1) WO2023049886A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240082371A (ko) 2021-09-27 2024-06-10 얀센 파마슈티카 엔브이 이미다조피리다진 il-17 억제제 화합물
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
WO2024138286A1 (en) * 2022-12-26 2024-07-04 Usynova Pharmaceuticals, Ltd. Il-17a modulators
WO2024163365A1 (en) * 2023-01-30 2024-08-08 Dice Alpha, Inc. Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof
CN121311483A (zh) * 2023-03-28 2026-01-09 詹森药业有限公司 含内酰胺的咪唑并哒嗪il-17抑制剂化合物
WO2025202922A1 (en) * 2024-03-27 2025-10-02 Janssen Pharmaceutica Nv Imidazopyridazine il-17 inhibitor compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI752400B (zh) * 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
GB201909190D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents
KR20230019507A (ko) 2020-04-30 2023-02-08 얀센 파마슈티카 엔.브이. Il-17의 조절제로서의 이미다조피리다진
WO2023025783A1 (en) 2021-08-23 2023-03-02 Leo Pharma A/S Small molecule modulators of il-17
KR20240082371A (ko) 2021-09-27 2024-06-10 얀센 파마슈티카 엔브이 이미다조피리다진 il-17 억제제 화합물
CN116143777A (zh) 2021-11-04 2023-05-23 四川海思科制药有限公司 一种可抑制il-17a的杂环化合物及其用途
TW202413363A (zh) 2021-11-04 2024-04-01 大陸商西藏海思科製藥有限公司 一種可抑制il-17a之雜環化合物及其用途

Also Published As

Publication number Publication date
US12215111B2 (en) 2025-02-04
MX2024003770A (es) 2024-06-19
CA3233625A1 (en) 2023-03-30
US20230147458A1 (en) 2023-05-11
UY39957A (es) 2023-04-14
EP4408529A1 (en) 2024-08-07
WO2023049886A1 (en) 2023-03-30
TW202329933A (zh) 2023-08-01
US20250206744A1 (en) 2025-06-26
JP2024536863A (ja) 2024-10-08
KR20240082371A (ko) 2024-06-10

Similar Documents

Publication Publication Date Title
AU2022348938A1 (en) Imidazopyridazine il-17 inhibitor compounds
US11702422B2 (en) Imidazopyridazines as modulators of IL-17
EP3559009B1 (en) Compositions and methods for inhibiting arginase activity
AU2022349687A1 (en) Imidazopyridazine il-17 inhibitor compounds
US12559496B2 (en) Imidazopyrimidines as modulators of IL-17
EP4408837A1 (en) Benzimidazole and azabenzimidazole il-17 inhibitor compounds
EP4688156A1 (en) Lactam-containing imidazopyridazine il-17 inhibitor compounds
CN118076606A (zh) 咪唑并哒嗪il-17抑制剂化合物
EA049269B1 (ru) Соединения ингибиторов il-17 на основе имидазопиридазина
CN118317962A (zh) 咪唑并哒嗪il-17抑制剂化合物
HK40056484A (en) Compositions and methods for inhibiting arginase activity
HK40011974A (en) Compositions and methods for inhibiting arginase activity
HK40011974B (en) Compositions and methods for inhibiting arginase activity